Few middle-aged women with severe mental symptoms use psychotropic drugs: The Women's Health in Lund Area (WHILA) Study

Abstract

Aims: In a population of middle-aged women a survey was carried out to ascertain the prevalence of mental symptoms and psychotropic drug use, and further to investigate whether severe mental symptoms are associated with social situation, alcohol consumption, smoking, and physical health. Methods: All women (n=10,766) aged 50—59 years and living in the Lund area were invited to the WHILA study, a health survey including laboratory examinations and a self-administered questionnaire; 6,917 (64.2%) participated. This study is based on the questionnaire only. Results: During the past three months 25.4% (n=1,709) had been troubled by none or 1 mental symptom (labelled ``absent/slight''), 52.8% (n=3,555) by 2—6 mental symptoms (``moderate'') and 21.8% (n=1,471) by 7—10 mental symptoms (``severe''). Among women with severe mental symptoms 15.4% regularly used psychotropic drugs, mainly antidepressants. A multiple logistic regression analysis showed that women with severe mental symptoms had higher odds for living alone (OR 1.7; CI 1.3—2.2) or as single parents (OR 2.1; CI 1.2—3.6), being university-educated (OR 1.5; CI 1.1—2.0), being on long-term sick-leave (OR 8.8; CI 3.0—25.5), using hormone replacement therapy (OR 1.3; CI 1.1—1.6), and having severe physical symptoms (136.8; CI 89.2—209.7) compared with women with absent/slight mental symptoms. Conclusion: Mental symptoms were common among the participating women. The presence of severe mental symptoms was strongly associated with severe physical symptoms. Few women with severe mental symptoms used psychotropic drugs. Middle-aged women with severe mental symptoms need to be identified and provided with appropriate psychopharmacological, hormonal, and/or psychosocial treatment.

Keywords

Mental symptoms middle age psychotropic drugs population-based study women

Get full access to this article

View all access options for this article.

References

Tibblin G. , Bengtsson C. , Furunes B. , Lapidus L. Symptoms by age and sex: The population studies of men and women in Gothenburg, Sweden. Scand J Prim Health Care 1990;8:9—17.

Al-Windi A. , Elmfeldt D. , Tibblin G. , Svardsudd K. The influence of sociodemographic characteristics on well-being and symptoms in a Swedish community: Results from a postal questionnaire survey. Scand J Prim Health Care 1999;17:201—9.

Van Wijk CM , Kolk AM Sex differences in physical symptoms: The contribution of symptom perception theory. Soc Sci Med 1997;45:231—46.

Pietraru C. , Barbui C. , Poggio L. , Tognoni G. Antidepressant drug prescribing in Italy, 2000: Analysis of a general practice database. Eur J Clin Pharmacol 2001;57:605—9.

Graham K. , Vidal-Zeballos D. Analyses of use of tranquillizers and sleeping pills across five surveys of the same population (1985—1991): The relationship with gender, age and use of other substances. Soc Sci Med 1998;46:381—95.

Apoteksbolaget, Statistik (Pharmacy, Statistics). Apotekets försäljning av humanläkemedel på recept 2000—2002 [Pharmacy sale of prescriptions for human medicine 2000— 2002].

Li C. , Wilawan K. , Samsioe G. , Lidfeldt J. , Agardh CD , Nerbrand C. Health profile of middle-aged women: The Women's Health in the Lund Area (WHILA) study. Hum Reprod 2002;17:1379—85.

Brace M. , McCauley E. Oestrogens and psychological well-being. Ann Med 1997;29:283—90.

Horwath E. , Johnson J. , Klerman GL , Weissman MM

What are the public health implications of subclinical depressive symptoms?

Psychiatr Q 1994;65:323—37.

10.

Korten A. , Henderson S. The Australian National Survey of Mental Health and Well-Being: Common psychological symptoms and disablement. Br J Psychiatry 2000; 177:325—30.

11.

Al-Windi A. , Elmfeldt D. , Svardsudd K. The influence of perceived well-being and reported symptoms on health care utilization: A population-based study. J Clin Epidemiol 2002;55:60—6.

12.

Krantz G. , Ostergren PO

Do common symptoms in women predict long spells of sickness absence? A prospective community-based study on Swedish women 40 to 50 years of age. Scand

J Public Health 2002;30:176—83.

13.

Stewart DE Physical symptoms of depression: Unmet needs in special populations. J Clin Psychiatry 2003;64:12—6.

14.

Tibblin G. , Tibblin B. , Peciva S. , Kullman S. , Svardsudd K. ``The Goteborg quality of life instrument'': An assessment of well-being and symptoms among men born 1913 and 1923. Methods and validity. Scand J Prim Health Care 1990;1:33—8.

15.

Bengtsson C. , Edstrom K. , Furunes B. , Sigurdsson JA , Tibblin G. Prevalence of subjectively experienced symptoms in a population sample of women with special reference to women with arterial hypertension. Scand J Prim Health Care 1987;5:155—62.

16.

Bardel A. , Wallander MA , Svardsudd K. Hormone replacement therapy and symptom reporting in menopausal women: A population-based study of 35—65-year-old women in mid-Sweden. Maturitas 2002;41:7—15.

17.

Riksförsäkringsverket, Statistik [The National Social Insurance Board, Statistics]. 2000:11.

18.

Van den Brandt PA , Petri H. , Dorant E. , Goldbohm RA , Van de Crommert S. Comparison of questionnaire information and pharmacy data on drug use. Pharm Weekbl Sci 1991;13:91—6.

19.

Osterling A. , Berglund M. Alcohol consumption and regular benzodiazepine use in 55-year-old female Malmo residents: Results of a health screening. Acta Psychiatr Scand 1996;94:141—8.

20.

Blennow G. , Romelsjo A. , Leifman H, Leifman A, Karlsson G. Sedatives and hypnotics in Stockholm: Social factors and kinds of use. Am J Public Health 1994;84:242—6.

21.

Ormel J. , Koeter MW , van den Brink W. , van de Willige G. Recognition, management, and course of anxiety and depression in general practice . Arch Gen Psychiatry 1991;48:700—6.

22.

Laukkala T. , Isometsa E. , Hamalainen J. , Heikkinen M. , Lindeman S. , Aro H. Antidepressant treatment of depression in the Finnish general population. Am J Psychiatry 2001; 158:2077—9.

23.

Blazer DG , Kessler RC , McGonagle KA , Swartz MS The prevalence and distribution of major depression in a national community sample: The National Comorbidity Survey. Am J Psychiatry 1994;151:979—86.

24.

Regier DA , Farmer ME , Rae DS , Myers JK , Kramer M. , Robins LN , George LK , Karno M. , Locke BZ One-month prevalence of mental disorders in the United States and sociodemographic characteristics: The Epidemiologic Catchment Area study. Acta Psychiatr Scand 1993; 88:35—47.

25.

Stadberg E. , Mattsson LA , Milsom I. The prevalence and severity of climacteric symptoms and the use of different treatment regimens in a Swedish population . Acta Obstet Gynecol Scand 1997;76:442—8.

26.

Armitage M. , Nooney J. , Evans S. Recent concerns surrounding HRT. Clin Endocrinol 2003;59:145—55.

27.

Biscup P. Risks and benefits of long-term hormone replacement therapy. Am J Health Syst Pharm 2003; 60:1419—25.

28.

Gazmararian J. , Baker D. , Parker R. , Blazer DG A multi-variate analysis of factors associated with depression: Evaluating the role of health literacy as a potential contributor . Arch Intern Med 2000;160:3307—14.

29.

På tal om kvinnor och män [On men and women], Statistiska Centralbyrån, Programmet för jämställdhetsstatistik [Statistics Sweden, Programme on equality statistics]. Örebro: SCB-tryck, 2000.

30.

Krantz G. , Ostergren PO Double exposure: The combined impact of domestic responsibilities and job strain on common symptoms in employed Swedish women . Eur J Public Health 2001;11:413—9.